Trial Profile
A Study to Evaluate the the Pharmacokinetic Interactions and Safety of MK-8742 (Elbasvir) Co-administered with Either Tenofovir-disoproxil-fumarate, Raltegravir, or Efavirenz in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Elbasvir (Primary) ; Raltegravir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B; Hepatitis C; HIV infections; HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 19 Dec 2015 New trial record